154 related articles for article (PubMed ID: 7634495)
1. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy.
Paschke R; Vassart G; Ludgate M
Clin Endocrinol (Oxf); 1995 Jun; 42(6):565-9. PubMed ID: 7634495
[No Abstract] [Full Text] [Related]
2. Graves' ophthalmopathy and the TSH receptor.
Franklyn JA
Lancet; 1993 Aug; 342(8867):318-9. PubMed ID: 8101579
[No Abstract] [Full Text] [Related]
3. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
4. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
5. Has the target autoantigen for Graves' ophthalmopathy been found?
McGregor AM
Lancet; 1998 Aug; 352(9128):595-6. PubMed ID: 9746018
[No Abstract] [Full Text] [Related]
6. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
7. New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease.
Graves PN; Davies TF
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):267-86, vi. PubMed ID: 10874529
[TBL] [Abstract][Full Text] [Related]
8. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
9. The 1985 Eastern Section AFCR Young Investigator award. Graves' disease: studies concerning TSH-receptor antibody formation and action.
Burman KD
Clin Res; 1986 Sep; 34(3):432-7. PubMed ID: 3757429
[No Abstract] [Full Text] [Related]
10. Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?
Bahn RS
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):287-96, vi. PubMed ID: 10874530
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
14. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
[TBL] [Abstract][Full Text] [Related]
15. [Current understanding of pathogenesis of Graves ophthalmopathy].
Ando T; Eguchi K
Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
[TBL] [Abstract][Full Text] [Related]
16. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
17. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
[No Abstract] [Full Text] [Related]
18. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
Burch HB; Sellitti D; Barnes SG; Nagy EV; Bahn RS; Burman KD
J Clin Endocrinol Metab; 1994 Jun; 78(6):1384-91. PubMed ID: 8200941
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
Tahara K; Ban T; Minegishi T; Kohn LD
Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
